| Year |
Citation |
Score |
| 2020 |
Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B, Kumar P, Kapoor P, Rosenberg A, Zonder JA, Faber E, ... ... Wagner LI, et al. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. The Lancet. Oncology. PMID 32866432 DOI: 10.1016/S1470-2045(20)30452-6 |
0.316 |
|
| 2020 |
Steffen McLouth LE, Zhao F, Owonikoko TK, Feliciano JL, Mohindra NA, Dahlberg SE, Wade JL, Srkalovic G, Lash BW, Leach JW, Leal TA, Aggarwal C, Cella D, Ramalingam SS, Wagner LI. Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial. Cancer Medicine. PMID 32860331 DOI: 10.1002/Cam4.3416 |
0.382 |
|
| 2020 |
Ailawadhi S, Jagannath S, Lee HC, Narang M, Rifkin RM, Terebelo HR, Durie BGM, Toomey K, Hardin JW, Gasparetto CJ, Wagner L, Omel JL, He M, Yue L, Flick ED, et al. Association between race and treatment patterns and survival outcomes in multiple myeloma: A connect MM registry analysis. Cancer. PMID 32706404 DOI: 10.1002/Cncr.33089 |
0.312 |
|
| 2020 |
Wong SF, Unger JM, Wade JL, Wagner LI, Lacouture ME, Humphries KC, Moseley A, Arnold K, Velasco MR, Floyd JD, Esparaz BT, Barzi A, Lenz HJ, Koczywas M, Dakhil S, et al. A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. Journal of Patient-Reported Outcomes. 4: 54. PMID 32642992 DOI: 10.1186/S41687-020-00220-X |
0.353 |
|
| 2020 |
Wagner LI, Gray RJ, Sparano JA, Whelan TJ, Garcia SF, Yanez B, Tevaarwerk AJ, Carlos RC, Albain KS, Olson JA, Goetz MP, Pritchard KI, Hayes DF, Geyer CE, Dees EC, et al. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901866. PMID 32271671 DOI: 10.1200/Jco.19.01866 |
0.363 |
|
| 2020 |
Khan SA, Zhao F, Solin LJ, Goldstein LJ, Cella D, Basik M, Golshan M, Julian TB, Pockaj BA, Lee CA, Razaq W, Sparano JA, Babiera GV, Dy IA, Jain S, ... ... Wagner LI, et al. A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: A trial of the ECOG-ACRIN Research Group (E2108). Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.18_Suppl.Lba2 |
0.368 |
|
| 2020 |
Dent SF, Reding K, Lesser GJ, Klepin HD, Wagner LI, Kitzman D, Brubaker PH, Mihalko S, Avis NE, Winkfield KM, Ky B, Crotts T, Kikuchi R, Calhoun T, Hundley WG. Understanding and predicting fatigue, cardiovascular (CV) decline & events after breast cancer treatment (UPBEAT): A prospective multi-center wake forest NCORP research-base study. Journal of Clinical Oncology. 38: TPS602-TPS602. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps602 |
0.384 |
|
| 2020 |
Tarhini AA, Zheng Y, Lee SJ, Hodi FS, Rao U, Cohen GI, Sondak VK, Kirkwood JM, Wagner LI. Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E22078 |
0.343 |
|
| 2020 |
Peipert J, Zhao F, Lee J, Hong F, Ip E, Gareen IF, O'Connell N, Carlos R, Stewart AK, Weiss M, Sparano JA, Cella D, Gray RJ, Wagner LI. Increase in side effect bother was associated with early treatment discontinuation in a clinical trial among multiple myeloma patients. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E19136 |
0.323 |
|
| 2020 |
Ailawadhi S, Lee HC, Omel J, Toomey K, Hardin JW, Gasparetto C, Jagannath S, Rifkin RM, Durie BG, Narang M, Terebelo HR, Wagner LI, Dhalla M, He M, Srinivasan S, et al. Impact of lenalidomide-bortezomib-dexamethasone (RVd) induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect MM Registry. Journal of Clinical Oncology. 38: 8518-8518. DOI: 10.1200/Jco.2020.38.15_Suppl.8518 |
0.316 |
|
| 2020 |
Sadigh G, Gray RJ, Yanez B, Wagner LI, Garcia SF, Sparano JA, Cella D, Carlos R. Breast cancer patients’ insurance status correlates with their adherence to endocrine therapy: Analysis of ECOG-ACRIN TAILORx trial. Journal of Clinical Oncology. 38: 7041-7041. DOI: 10.1200/Jco.2020.38.15_Suppl.7041 |
0.396 |
|
| 2020 |
Bradbury AR, Lee J, Gaieski JB, Li S, Gareen IF, Flaherty K, Herman BA, DeMichele A, Domchek SM, Maxwell KN, Onitilo AA, Virani S, Park S, Faller BA, Grant SC, ... ... Wagner LI, et al. Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing tumor genetic testing: Results from the ECOG-ACRIN NCI Community Oncology Research Program (NCORP; EAQ152) COMET trial. Journal of Clinical Oncology. 38: 2008-2008. DOI: 10.1200/Jco.2020.38.15_Suppl.2008 |
0.324 |
|
| 2020 |
Obeng-Gyasi S, O'Neil A, Zhao F, Kircher SM, Lava TR, Wagner LI, Miller KD, Sparano JA, Sledge GW, Carlos RC. Abstract PD10-09: Impact of insurance and socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Pd10-09 |
0.37 |
|
| 2019 |
Jagannath S, Rifkin RM, Gasparetto CJ, Toomey K, Durie BGM, Hardin JW, Terebelo HR, Wagner L, Narang M, Ailawadhi S, Omel JL, Srinivasan S, He M, Ung B, Kitali A, et al. Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry. Clinical Lymphoma, Myeloma & Leukemia. PMID 32144027 DOI: 10.1016/J.Clml.2019.10.002 |
0.31 |
|
| 2019 |
Chakravarthy AB, Zhao F, Meropol NJ, Flynn PJ, Wagner LI, Sloan J, Diasio RB, Mitchell EP, Catalano P, Giantonio BJ, Catalano RB, Haller DG, Awan RA, Mulcahy MF, O'Brien TE, et al. Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204). The Oncologist. PMID 31852811 DOI: 10.1634/Theoncologist.2019-0437 |
0.362 |
|
| 2019 |
Wagner LI, Duffecy J, Begale M, Victorson D, Golden SL, Smith ML, Penedo FJ, Mohr DC, Cella D. Development and refinement of FoRtitude: An eHealth intervention to reduce fear of recurrence (FoR) among breast cancer survivors. Psycho-Oncology. PMID 31760667 DOI: 10.1002/Pon.5297 |
0.308 |
|
| 2019 |
Ailawadhi S, Jagannath S, Narang M, Rifkin RM, Terebelo HR, Toomey K, Durie BGM, Hardin JW, Gasparetto CJ, Wagner L, Omel JL, Kumar V, Yue L, Kitali A, Agarwal A, et al. Connect MM Registry as a national reference for United States multiple myeloma patients. Cancer Medicine. PMID 31701679 DOI: 10.1002/Cam4.2656 |
0.326 |
|
| 2019 |
Sparano JA, Gray RJ, Makower DF, Albain KS, Saphner TJ, Badve SS, Wagner LI, Kaklamani VG, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Toppmeyer DL, Brufsky AM, et al. Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial. Jama Oncology. PMID 31566680 DOI: 10.1001/Jamaoncol.2019.4794 |
0.362 |
|
| 2019 |
Rand KL, Cohee AA, Monahan PO, Wagner LI, Shanahan ML, Champion VL. Coping Among Breast Cancer Survivors: A Confirmatory Factor Analysis of the Brief COPE. Journal of Nursing Measurement. 27: 259-276. PMID 31511409 DOI: 10.1891/1061-3749.27.2.259 |
0.345 |
|
| 2019 |
Terebelo HR, Abonour R, Gasparetto CJ, Toomey K, Durie BGM, Hardin JW, Jagannath S, Wagner L, Narang M, Flick ED, Srinivasan S, Yue L, Kitali A, Agarwal A, Rifkin RM, et al. Development of a prognostic model for overall survival in multiple myeloma using the Connect MM Patient Registry. British Journal of Haematology. PMID 31382320 DOI: 10.1111/Bjh.16139 |
0.357 |
|
| 2019 |
Garcia SF, Wortman K, Cella D, Wagner LI, Bass M, Kircher S, Pearman T, Penedo FJ. Implementing electronic health record-integrated screening of patient-reported symptoms and supportive care needs in a comprehensive cancer center. Cancer. PMID 31373682 DOI: 10.1002/Cncr.32172 |
0.351 |
|
| 2019 |
Upshaw JN, Ruthazer R, Miller KD, Parsons SK, Erban JK, O'Neill AM, Demissei B, Sledge G, Wagner L, Ky B, Kent DM. Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off. Clinical Breast Cancer. PMID 31175052 DOI: 10.1016/J.Clbc.2019.04.012 |
0.335 |
|
| 2019 |
Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Wagner LI, et al. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. The New England Journal of Medicine. PMID 31157962 DOI: 10.1056/Nejmoa1904819 |
0.343 |
|
| 2019 |
Radeke EK, Lee J, Patel A, Zaren HA, Fisch MJ, Wagner LI. Reproductive health in cancer. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps6649 |
0.314 |
|
| 2019 |
Reding K, D'Agostino R, Lesser GJ, Klepin HD, Wagner LI, Kitzman D, Brubaker PH, Mihalko S, Jordan J, Avis NE, Winkfield KM, Ky B, Dent SF, Crotts T, Calhoun T, et al. Understanding and predicting fatigue, cardiovascular (CV) decline, and events after breast cancer treatment (UPBEAT): A prospective cardio-oncology study. Journal of Clinical Oncology. 37: TPS11634-TPS11634. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps11634 |
0.392 |
|
| 2019 |
Lonial S, Jacobus SJ, Weiss M, Kumar S, Orlowski RZ, Kaufman JL, Yacoub A, Buadi F, O'Brien TE, Matous J, Anderson DM, Emmons R, Dhodapkar MV, Wagner LI, Rajkumar SV. E3A06: Randomized phase III trial of lenalidomide versus observation alone in patients with asymptomatic high-risk smoldering multiple myeloma. Journal of Clinical Oncology. 37: 8001-8001. DOI: 10.1200/Jco.2019.37.15_Suppl.8001 |
0.336 |
|
| 2019 |
Lee HC, Ailawadhi S, Gasparetto C, Jagannath S, Rifkin RM, Durie BGM, Narang M, Terebelo HR, Toomey K, Hardin JW, Wagner LI, Omel JL, Srinivasan S, Liu L, Dhalla M, et al. Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect® MM Registry Blood. 134: 3129-3129. DOI: 10.1182/Blood-2019-126205 |
0.306 |
|
| 2019 |
Wagner LI, Toomey K, Ailawadhi S, Jagannath S, Gasparetto C, Durie BGM, Narang M, Rifkin RM, Terebelo HR, Omel JL, Hardin JW, Lee HC, Srinivasan S, Liu L, Dhalla M, et al. Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect® MM Registry Blood. 134: 1843-1843. DOI: 10.1182/Blood-2019-126143 |
0.326 |
|
| 2019 |
Jagannath S, Narang M, Ailawadhi S, Rifkin R, Terebelo H, Toomey K, Durie B, Hardin J, Gasparetto C, Wagner L, Omel J, Srinivasan S, Kitali A, Agarwal A, Abonour R. PS1384 TREATMENT CHOICES AND OUTCOMES FOR PATIENTS WITH MULTIPLE MYELOMA AFTER RELAPSE ON LENALIDOMIDE MAINTENANCE THERAPY: RESULTS FROM THE CONNECT® MM REGISTRY Hemasphere. 3: 634. DOI: 10.1182/Blood-2018-99-110877 |
0.349 |
|
| 2019 |
Wagner L, Gray R, Garcia S, Whelan T, Tevarweerk A, Yanez B, Carlos R, Gareen I, McCaskill-Stevens W, Cella D, Sparano J, Sledge G. Abstract GS6-03: Symptoms and health-related quality of life on endocrine therapy alone (E) versus chemoendocrine therapy (C+E): TAILORx patient-reported outcomes results Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Gs6-03 |
0.402 |
|
| 2019 |
Sparano J, Gray R, Makower D, Albain K, Saphner T, Badve S, Wagner L, Mihalcioiu C, Desbiens C, Hayes D, Dees E, Geyer C, Olson J, Wood W, Lively T, et al. Clinical outcomes by chemotherapy regimen in patients with RS 26-100 in TAILORx Annals of Oncology. 30: v854. DOI: 10.1093/Annonc/Mdz394.004 |
0.378 |
|
| 2018 |
Owonikoko TK, Dahlberg SE, Sica GL, Wagner LI, Wade JL, Srkalovic G, Lash BW, Leach JW, Leal TB, Aggarwal C, Ramalingam SS. Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800264. PMID 30523756 DOI: 10.1200/Jco.18.00264 |
0.309 |
|
| 2018 |
Lucas AR, Bass MB, Rothrock NE, O'Connor ML, Sorkin MR, Nawyn J, Albinali F, Wagner LI. Development of an eHealth System to Capture and Analyze Patient Sensor and Self-Report Data: Mixed-Methods Assessment of Potential Applications to Improve Cancer Care Delivery. Jmir Medical Informatics. 6: e46. PMID 30348634 DOI: 10.2196/Medinform.9525 |
0.33 |
|
| 2018 |
Upshaw JN, O'Neill A, Carver JR, Dimond EP, Denlinger CS, Kircher SM, Wagner LI, Ky B, Brell JM. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal. Clinical Colorectal Cancer. PMID 30348619 DOI: 10.1016/J.Clcc.2018.08.001 |
0.337 |
|
| 2018 |
Apple AC, Schroeder MP, Ryals AJ, Wagner LI, Cella D, Shih PA, Reilly J, Penedo FJ, Voss JL, Wang L. Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy. Neuroimage. Clinical. 20: 110-118. PMID 30094161 DOI: 10.1016/J.Nicl.2018.07.010 |
0.327 |
|
| 2018 |
Abonour R, Wagner L, Durie BGM, Jagannath S, Narang M, Terebelo HR, Gasparetto CJ, Toomey K, Hardin JW, Kitali A, Gibson CJ, Srinivasan S, Swern AS, Rifkin RM. Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry. Annals of Hematology. PMID 30056582 DOI: 10.1007/S00277-018-3446-Y |
0.349 |
|
| 2018 |
Rifkin RM, Jagannath S, Durie BGM, Narang M, Terebelo HR, Gasparetto CJ, Toomey K, Hardin JW, Wagner L, Parikh K, Abouzaid S, Srinivasan S, Kitali A, Zafar F, Abonour R. Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-Only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry. Clinical Therapeutics. PMID 30007443 DOI: 10.1016/J.Clinthera.2018.05.017 |
0.312 |
|
| 2018 |
Jagannath S, Abonour R, Durie BGM, Narang M, Terebelo HR, Gasparetto CJ, Toomey K, Hardin JW, Wagner L, Agarwal A, Srinivasan S, Kitali A, Flick ED, Sturniolo M, Rifkin RM. Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM. Blood Advances. 2: 1608-1615. PMID 29986853 DOI: 10.1182/Bloodadvances.2018017186 |
0.373 |
|
| 2018 |
Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, et al. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. The New England Journal of Medicine. PMID 29860917 DOI: 10.1056/Nejmoa1804710 |
0.358 |
|
| 2018 |
Wagner LI, Zhao F, Goss PE, Chapman JW, Shepherd LE, Whelan TJ, Mattar BI, Bufill JA, Schultz WC, LaFrancis IE, Nagargoje GG, Vemuri R, Nikcevich DA, Sledge GW, Cella D. Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03). Breast Cancer Research and Treatment. PMID 29455298 DOI: 10.1007/S10549-018-4713-2 |
0.408 |
|
| 2018 |
Jagannath S, Rifkin RM, Gasparetto C, Toomey K, Durie BG, Hardin JW, Terebelo HR, Wagner LI, Narang M, Ailawadhi S, Srinivasan S, YoussefAgha A, Ung B, Kitali A, Flick ED, et al. Treatment (tx) journeys in newly diagnosed multiple myeloma (NDMM) patients (pts): Results from the Connect MM Registry. Journal of Clinical Oncology. 36: 8041-8041. DOI: 10.1200/Jco.2018.36.15_Suppl.8041 |
0.31 |
|
| 2018 |
Abonour R, Rifkin R, Gasparetto C, Toomey K, Durie B, Hardin J, Terebelo H, Jagannath S, Narang M, Ailawadhi S, Srinivasan S, Kitali A, Agarwal A, Wagner L. Impact of initial treatment (tx) on HRQoL and outcomes in patients (pts) with newly diagnosed multiple myeloma (NDMM) without intent for immediate transplant (SCT): Results from the Connect® MM registry Annals of Oncology. 29: viii360. DOI: 10.1093/Annonc/Mdy286.003 |
0.308 |
|
| 2018 |
Morgans AK, Chen YH, Jerrard D, Carducci MA, Dipaola R, Wagner L, Cella D, Sweeney C. Association between patient reported quality of life (QOL) and survival: Analysis of E3805 chemohormonal androgen ablation randomized trial in prostate cancer. Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy284.041 |
0.351 |
|
| 2017 |
Zhao F, Cella D, Manola J, DiPaola RS, Wagner LI, Haas NSB. Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29274030 DOI: 10.1007/S00520-017-4027-7 |
0.338 |
|
| 2017 |
Kytola V, Topaloglu U, Miller LD, Bitting RL, Goodman MM, D Agostino RB, Desnoyers RJ, Albright C, Yacoub G, Qasem SA, DeYoung B, Thorsson V, Shmulevich I, Yang M, Shcherban A, ... ... Wagner LI, et al. Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center. Theranostics. 7: 2914-2923. PMID 28824725 DOI: 10.7150/Thno.20355 |
0.318 |
|
| 2017 |
Apple AC, Ryals AJ, Alpert KI, Wagner LI, Shih PA, Dokucu M, Cella D, Penedo FJ, Voss JL, Wang L. Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. Neuroimage. Clinical. 14: 685-691. PMID 28377882 DOI: 10.1016/J.Nicl.2017.03.004 |
0.347 |
|
| 2017 |
Chung A, Stover AM, Wagner LI, LeBlanc TW, Topalaglu U, Zafar Y, Zullig LL, Smeltzer P, Basch EM. Harmonization of patient-reported outcomes into EHRs at four cancer hospital outpatient clinics for patient care and quality assessment. Journal of Clinical Oncology. 35: 129-129. DOI: 10.1200/Jco.2017.35.8_Suppl.129 |
0.369 |
|
| 2017 |
Rifkin RM, Jagannath S, Durie BG, Shah JJ, Narang M, Terebelo HR, Gasparetto C, Toomey K, Hardin JW, Wagner LI, Parikh K, Abouzaid S, Srinivasan S, Kitali A, Zafar F, et al. Treatment outcomes and healthcare resource utilization (HRU) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) with lenalidomide (LEN) only or no maintenance: Connect MM registry. Journal of Clinical Oncology. 35: e19527-e19527. DOI: 10.1200/Jco.2017.35.15_Suppl.E19527 |
0.325 |
|
| 2017 |
Jagannath S, Abonour R, Durie BG, Shah JJ, Narang M, Terebelo HR, Gasparetto C, Toomey K, Hardin JW, Wagner LI, Agarwal A, Srinivasan S, Kitali A, Zafar F, Sturniolo M, et al. Impact of post-autologous stem cell transplant (ASCT) maintenance therapy on outcomes in patients (Pts) with newly diagnosed multiple myeloma (NDMM) using the large prospective community-based Connect MM registry. Journal of Clinical Oncology. 35: 8040-8040. DOI: 10.1200/Jco.2017.35.15_Suppl.8040 |
0.325 |
|
| 2017 |
Jagannath S, Rifkin RM, Gasparetto CJ, Toomey K, Durie BGM, Hardin JW, Terebelo HR, Wagner L, Narang M, Srinivasan S, YoussefAgha A, Kitali A, Larkins G, Agarwal A, Abonour R. Development of a Predictive Model of Multiple Myeloma (MM) Patient (pt) Outcomes Based on Treatment Class Transitions Using the Connect® MMpatient Registry Blood. 130: 3122-3122. DOI: 10.1182/Blood.V130.Suppl_1.3122.3122 |
0.301 |
|
| 2017 |
Terebelo HR, Abonour R, Gasparetto CJ, Toomey K, Durie BGM, Hardin JW, Jagannath S, Wagner L, Narang M, Srinivasan S, Yue L, Zafar F, Kitali A, Agarwal A, Rifkin RM. Development of a Prognostic Model That Predicts 3- and 5-Year Overall Survival in Multiple Myeloma Using the Connect® MM Patient Registry Blood. 130: 1842-1842. DOI: 10.1182/Blood.V130.Suppl_1.1842.1842 |
0.344 |
|
| 2016 |
Cohee AA, Monahan P, Stump TE, Miller K, Wagner L, Cella D, Sledge G. Quality of life difficulties in partners of young breast cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 188. PMID 28151346 DOI: 10.1200/Jco.2016.34.3_Suppl.188 |
0.314 |
|
| 2016 |
Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, Trevarthen DR, Balkrishna J, Murphy BA, Agrawal N, Colevas AD, et al. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016683300. PMID 28029303 DOI: 10.1200/Jco.2016.68.3300 |
0.313 |
|
| 2016 |
Wagner LI, Pugh SL, Small W, Kirshner J, Sidhu K, Bury MJ, DeNittis AS, Alpert TE, Tran B, Bloom BF, Mai J, Yeh A, Sarma K, Becker M, James J, et al. Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. Cancer. PMID 27861753 DOI: 10.1002/Cncr.29969 |
0.329 |
|
| 2016 |
Trosman JR, Carlos RC, Simon MA, Madden DL, Gradishar WJ, Benson AB, Rapkin BD, Weiss ES, Gareen IF, Wagner LI, Khan SA, Bunce MM, Small A, Weldon CB. Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care Delivery. Journal of Oncology Practice / American Society of Clinical Oncology. PMID 27577619 DOI: 10.1200/Jop.2016.013573 |
0.322 |
|
| 2016 |
Williams ME, Hong F, Gascoyne RD, Wagner LI, Krauss JC, Habermann TM, Swinnen LJ, Schuster SJ, Peterson CG, Sborov MD, Martin SE, Weiss M, Ehmann WC, Horning SJ, Kahl BS. Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402. British Journal of Haematology. PMID 26970533 DOI: 10.1111/Bjh.14007 |
0.311 |
|
| 2016 |
Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, et al. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet (London, England). PMID 26969090 DOI: 10.1016/S0140-6736(16)00559-6 |
0.371 |
|
| 2016 |
Evens AM, Hong F, Habermann TM, Advani RH, Gascoyne RD, Witzig TE, Quon A, Wagner LI, Ansell SM, Petrich AM, Chang JE, O'Brien TE, Cheema PS, Cescon T, Sturtz K, et al. Effect of bortezomib on complete remission (CR) rate when added to bendamustine-rituximab (BR) in previously untreated high-risk (HR) follicular lymphoma (FL): A randomized phase II trial of the ECOG-ACRIN Cancer Research Group (E2408). Journal of Clinical Oncology. 34: 7507-7507. DOI: 10.1200/Jco.2016.34.15_Suppl.7507 |
0.313 |
|
| 2016 |
Li S, Ferris RL, Holsinger FC, Weinstein GS, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Wagner LI, Ringash J, Lewin JS, Mendez E, Ridge JA, Richmon J, et al. E3311 trial of transoral surgery for oropharynx cancer: Implementation of a novel surgeon credentialing and quality assurance process. Journal of Clinical Oncology. 34: 6054-6054. DOI: 10.1200/Jco.2016.34.15_Suppl.6054 |
0.329 |
|
| 2016 |
Connolly R, Zhao F, Miller K, Tevaarwerk A, Wagner L, Lee M, Murray J, Gray R, Piekarz R, Zujewski J, Sparano J. Abstract OT2-01-04: E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN cancer research group Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Ot2-01-04 |
0.402 |
|
| 2015 |
Pearman T, Garcia S, Penedo F, Yanez B, Wagner L, Cella D. Implementation of distress screening in an oncology setting. The Journal of Community and Supportive Oncology. 13: 423-8. PMID 26863872 DOI: 10.12788/Jcso.0198 |
0.334 |
|
| 2015 |
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, ... ... Wagner LI, et al. Cancer-Related Fatigue, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 1012-39. PMID 26285247 DOI: 10.6004/Jnccn.2015.0122 |
0.404 |
|
| 2015 |
Kaiser K, Beaumont JL, Webster K, Yount SE, Wagner LI, Kuzel TM, Cella D. Development and validation of the functional assessment of cancer therapy-antiangiogenesis subscale. Cancer Medicine. 4: 690-8. PMID 25619758 DOI: 10.1002/Cam4.385 |
0.347 |
|
| 2015 |
Wagner LI, Zhao F, Hong F, Williams ME, Gascoyne RD, Krauss JC, Advani RH, Go RS, Habermann TM, Leach JW, O'Connor B, Schuster SJ, Cella D, Horning SJ, Kahl BS. Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 740-8. PMID 25605841 DOI: 10.1200/Jco.2014.57.6801 |
0.329 |
|
| 2015 |
Wagner LI, Schink J, Bass M, Patel S, Diaz MV, Rothrock N, Pearman T, Gershon R, Penedo FJ, Rosen S, Cella D. Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care. Cancer. 121: 927-34. PMID 25376427 DOI: 10.1002/Cncr.29104 |
0.344 |
|
| 2015 |
Fisch MJ, Zhao F, Manola J, Miller AH, Pirl WF, Wagner LI. Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors. Psycho-Oncology. 24: 523-32. PMID 24930693 DOI: 10.1002/Pon.3606 |
0.359 |
|
| 2015 |
Haas NB, Manola J, Uzzo RG, Atkins MB, Wilding G, Pins M, Jewett MAS, Kane CJ, Cella D, Wagner LI, Coomes B, Wood CG, Dutcher JP, Flaherty K, DiPaola RS. Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial. Journal of Clinical Oncology. 33: 403-403. DOI: 10.1200/Jco.2015.33.7_Suppl.403 |
0.31 |
|
| 2015 |
Cmelak A, Li S, Marur S, Zhao W, Westra WH, Chung CH, Gillison ML, Gilbert J, Bauman JE, Wagner LI, Ferris RL, Trevarthen DR, Murphy BA, Galloway T, Burtness B. Symptom reduction from IMRT dose deintensification: Results from ECOG 1308 using the Vanderbilt Head and Neck Symptom Survey version 2 (VHNSS V2). Journal of Clinical Oncology. 33: 6021-6021. DOI: 10.1200/Jco.2015.33.15_Suppl.6021 |
0.309 |
|
| 2015 |
Connolly RM, Zhao F, Miller KD, Tevaarwerk AJ, Wagner LI, Lee M, Murray J, Gray R, Piekarz RL, Zujewski JAA, Sparano JA. Abstract OT2-1-06: E2112: A randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Ot2-1-06 |
0.405 |
|
| 2014 |
Jacobs DI, Kumthekar P, Stell BV, Grimm SA, Rademaker AW, Rice L, Chandler JP, Muro K, Marymont M, Helenowski IB, Wagner LI, Raizer JJ. Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden. Neuro-Oncology Practice. 1: 47-54. PMID 26034616 DOI: 10.1093/Nop/Npu004 |
0.374 |
|
| 2014 |
Tevaarwerk AJ, Wang M, Zhao F, Fetting JH, Cella D, Wagner LI, Martino S, Ingle JN, Sparano JA, Solin LJ, Wood WC, Robert NJ. Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3948-58. PMID 25349302 DOI: 10.1200/Jco.2014.55.6993 |
0.339 |
|
| 2014 |
Kahl BS, Hong F, Williams ME, Gascoyne RD, Wagner LI, Krauss JC, Habermann TM, Swinnen LJ, Schuster SJ, Peterson CG, Sborov MD, Martin SE, Weiss M, Ehmann WC, Horning SJ. Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3096-102. PMID 25154829 DOI: 10.1200/Jco.2014.56.5853 |
0.302 |
|
| 2014 |
Champion VL, Wagner LI, Monahan PO, Daggy J, Smith L, Cohee A, Ziner KW, Haase JE, Miller KD, Pradhan K, Unverzagt FW, Cella D, Ansari B, Sledge GW. Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer. 120: 2237-46. PMID 24891116 DOI: 10.1002/Cncr.28737 |
0.357 |
|
| 2014 |
Sanford SD, Zhao F, Salsman JM, Chang VT, Wagner LI, Fisch MJ. Symptom burden among young adults with breast or colorectal cancer. Cancer. 120: 2255-63. PMID 24890659 DOI: 10.1002/Cncr.28297 |
0.369 |
|
| 2014 |
Jones D, Zhao F, Fisch MJ, Wagner LI, Patrick-Miller LJ, Cleeland CS, Mendoza TR. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clinical Genitourinary Cancer. 12: 41-9. PMID 24126238 DOI: 10.1016/J.Clgc.2013.07.003 |
0.392 |
|
| 2014 |
Sanford SD, Beaumont JL, Butt Z, Sweet JJ, Cella D, Wagner LI. Prospective longitudinal evaluation of a symptom cluster in breast cancer. Journal of Pain and Symptom Management. 47: 721-30. PMID 23880589 DOI: 10.1016/J.Jpainsymman.2013.05.010 |
0.33 |
|
| 2014 |
Wagner-Johnston ND, Gopal AK, Kahl BS, De Vos S, Schuster SJ, Jurczak W, Flinn I, Flowers C, Martin P, Viardot A, Blum KA, Goy A, Davies AJ, Zinzani PL, Dreyling MH, ... Wagner LI, et al. Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non-Hodgkin lymphoma (iNHL). Journal of Clinical Oncology. 32: e19554-e19554. DOI: 10.1200/Jco.2014.32.15_Suppl.E19554 |
0.386 |
|
| 2014 |
Ghia P, O'Brien SM, Hillmen P, Furman RR, Coutre SE, Sharman JP, Cheson BD, Pagel JM, Barrientos JC, Zelenetz AD, Kipps TJ, Flinn I, Eradat HA, Lamanna N, Hallek MJ, ... ... Wagner LI, et al. Health-related quality of life (HRQL) impact of idelalisib (IDELA) in patients (pts) with relapsed chronic lymphocytic leukemia (CLL): Phase 3 results. Journal of Clinical Oncology. 32: 7099-7099. DOI: 10.1200/Jco.2014.32.15_Suppl.7099 |
0.316 |
|
| 2014 |
Tevaarwerk A, Lee J, Sesto ME, Terhaar A, Smith ML, Cleeland CS, Wagner LI, Fisch M. Factors associated with loss of employment among metastatic patients. Journal of Clinical Oncology. 32: 6585-6585. DOI: 10.1200/Jco.2014.32.15_Suppl.6585 |
0.399 |
|
| 2013 |
Hamann HA, Lee JW, Schiller JH, Horn L, Wagner LI, Chang VT, Fisch MJ. Clinician perceptions of care difficulty, quality of life, and symptom reports for lung cancer patients: an analysis from the Symptom Outcomes and Practice patterns (SOAPP) study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 1474-83. PMID 24189514 DOI: 10.1097/01.Jto.0000437501.83763.5D |
0.401 |
|
| 2013 |
Mendoza TR, Zhao F, Cleeland CS, Wagner LI, Patrick-Miller LJ, Fisch MJ. The validity and utility of the M. D. Anderson symptom inventory in patients with breast cancer: Evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group Clinical Breast Cancer. 13: 325-334. PMID 23816985 DOI: 10.1016/J.Clbc.2013.02.014 |
0.396 |
|
| 2013 |
Wagner LI, Spiegel D, Pearman T. Using the science of psychosocial care to implement the New American College of Surgeons Commission on Cancer distress screening standard Jnccn Journal of the National Comprehensive Cancer Network. 11: 214-221. PMID 23411387 DOI: 10.6004/Jnccn.2013.0028 |
0.341 |
|
| 2013 |
Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL, Dudley MM, Fleishman S, Fulcher CD, Greenberg DB, Greiner CB, Handzo RGF, Hoofring L, Hoover C, Jacobsen PB, ... ... Wagner LI, et al. Distress Management: Clinical practice guidelines in oncology Jnccn Journal of the National Comprehensive Cancer Network. 11: 190-209. PMID 23411386 DOI: 10.6004/Jnccn.2013.0027 |
0.353 |
|
| 2013 |
Tevaarwerk AJ, Lee JW, Sesto ME, Buhr KA, Cleeland CS, Manola J, Wagner LI, Chang VTS, Fisch MJ. Employment outcomes among survivors of common cancers: The Symptom Outcomes and Practice Patterns (SOAPP) study Journal of Cancer Survivorship. 7: 191-202. PMID 23378060 DOI: 10.1007/S11764-012-0258-2 |
0.348 |
|
| 2013 |
Wagner LI, Berg SR, Gandhi M, Hlubocky FJ, Webster K, Aneja M, Cella D, Lacouture ME. The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18). Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 1033-41. PMID 23128934 DOI: 10.1007/S00520-012-1623-4 |
0.364 |
|
| 2013 |
Tevaarwerk AJ, Gray RJ, Schneider BP, Smith ML, Wagner LI, Fetting JH, Davidson N, Goldstein LJ, Miller KD, Sparano JA. Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years. Cancer. 119: 1140-8. PMID 23065954 DOI: 10.1002/Cncr.27819 |
0.373 |
|
| 2013 |
Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D. Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 959-67. PMID 23052918 DOI: 10.1007/S00520-012-1612-7 |
0.339 |
|
| 2013 |
Yount S, Kaiser K, Beaumont JL, Webster K, Wagner LI, Schenk TL, Kuzel T, Cella D. Development and validation of the functional assessment of cancer therapy: Antiangiogenesis (FACT-AntiA). Journal of Clinical Oncology. 31: e20527-e20527. DOI: 10.1200/Jco.2013.31.15_Suppl.E20527 |
0.385 |
|
| 2013 |
Wagner LI, Pugh SL, Small W, Kirshner JJ, Sidhu K, Bury MJ, DeNittis AS, Alpert TE, Tran BN, Bloom B, Mai J, Bruner D. Screening for depression in community-based radiation oncology settings: Results from RTOG 0841. Journal of Clinical Oncology. 31: 9527-9527. DOI: 10.1200/Jco.2013.31.15_Suppl.9527 |
0.327 |
|
| 2012 |
Zhao F, Manola J, Miller AH, Pirl WF, Wagner LI. Patterns of antidepressant use in patients with cancer: An analysis from SOAPP (E2Z02: Symptom Outcomes and Practice Patterns). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 59. PMID 28146972 DOI: 10.1200/Jco.2012.30.34_Suppl.59 |
0.305 |
|
| 2012 |
Wagner LI, Robinson D, Weiss M, Katz M, Greipp P, Fonseca R, Cella D. Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction. Journal of Pain and Symptom Management. 43: 1094-104. PMID 22575718 DOI: 10.1016/J.Jpainsymman.2011.06.019 |
0.362 |
|
| 2012 |
Joly F, Lange M, Rigal O, Correia H, Giffard B, Beaumont JL, Clisant S, Wagner L. French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3 Supportive Care in Cancer. 20: 3297-3305. PMID 22549504 DOI: 10.1007/S00520-012-1439-2 |
0.327 |
|
| 2012 |
Jacobsen PB, Wagner LI. A new quality standard: The integration of psychosocial care into routine cancer care Journal of Clinical Oncology. 30: 1154-1159. PMID 22412134 DOI: 10.1200/Jco.2011.39.5046 |
0.327 |
|
| 2012 |
Patrick-Miller LJ, Zhao F, Cleeland CS, Wagner LI, Fisch M, Mendoza TR. Validity and utility of the University of Texas M. D. Anderson Symptom Inventory (MDASI) among prostate cancer patients: Data from E2Z02: Symptom Outcomes and Practice Patterns (SOAPP). Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E15173 |
0.388 |
|
| 2012 |
Lai J, Krull KR, Zelko F, Wagner LI, Cella D, Goldman S. Parent-reported cognition and its clinical applications in pediatric oncology. Journal of Clinical Oncology. 30: 9532-9532. DOI: 10.1200/Jco.2012.30.15_Suppl.9532 |
0.32 |
|
| 2012 |
Mendoza TR, Zhao F, Cleeland CS, Wagner LI, Patrick-Miller LJ, Fisch M. Understanding the symptom experience of breast cancer outpatients: The validity and utility of the M.D. Anderson Symptom Inventory (MDASI). Journal of Clinical Oncology. 30: 9106-9106. DOI: 10.1200/Jco.2012.30.15_Suppl.9106 |
0.407 |
|
| 2012 |
Manola J, Zhao F, Miller AH, Pirl WF, Wagner LI, Fisch M. Patterns of antidepressant use in cancer patients (pts): An analysis from SOAPP (ECOG E2Z02: Symptom Outcomes and Practice Patterns). Journal of Clinical Oncology. 30: 9016-9016. DOI: 10.1200/Jco.2012.30.15_Suppl.9016 |
0.303 |
|
| 2012 |
Wagner LI, Zhao F, Williams ME, Gascoyne RD, Krauss JC, Cella D, Horning SJ, Kahl BS. Quality of Life Results From Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Indolent Non-Hodgkin's Lymphoma Blood. 120: 235-235. DOI: 10.1182/Blood.V120.21.235.235 |
0.364 |
|
| 2012 |
Wagner LI, Gray R, Sledge G, Whelan T, Hayes D, Geyer C, Dees EC, Cella D, Sparano JA. Abstract P2-12-02: Comorbidities and patient-reported cognitive function among women with stage I-II breast cancer randomized to hormonal therapy (HT) alone versus chemotherapy followed by hormonal therapy (C+HT) treated on theTrial Assigning IndividuaLized Options Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-12-02 |
0.34 |
|
| 2011 |
Wagner LI, Duffecy J, Lehman KA, Sanford SD, Begale M, Nawacki E, Mohr DC. Randomized clinical trial to evaluate an e-health intervention for fear of cancer recurrence, anxiety, and depression among cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: TPS237. PMID 28023515 DOI: 10.1200/Jco.2011.29.15_Suppl.Tps237 |
0.317 |
|
| 2011 |
Wagner LI, Zickl L, Smith ML, Cella D, Coles C, Patrick-Miller LJ, Manola J, Fisch M. Prospective assessment of symptom burden among cancer survivors with common solid tumors: Results from ECOG trial E2Z02. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9137. PMID 28022379 DOI: 10.1200/Jco.2011.29.15_Suppl.9137 |
0.37 |
|
| 2011 |
Stell BV, Jacobs D, Grimm SA, Rademaker A, Rice L, Schwartz MA, Muro K, Marymont MH, Chandler J, Helenowski IB, Wagner LI, Raizer JJ, Bennett CL. Quality-of-life concordance between patients with malignant gliomas and their caregivers: Updated data. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9053. PMID 28021605 DOI: 10.1200/Jco.2011.29.15_Suppl.9053 |
0.317 |
|
| 2011 |
Chang VT, Zhao F, Wagner LI, Sanford SD, Salsman J, Fisch M. Symptom burden and change among adolescent/young adult (AYA) patients with breast, lung, colorectal, or prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9064. PMID 28021570 DOI: 10.1200/Jco.2011.29.15_Suppl.9064 |
0.395 |
|
| 2011 |
Loehrer PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, Flynn P, Ramanathan RK, Crane CH, Alberts SR, Benson AB. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial Journal of Clinical Oncology. 29: 4105-4112. PMID 21969502 DOI: 10.1200/Jco.2011.34.8904 |
0.366 |
|
| 2011 |
Cella D, Wang M, Wagner L, Miller K. Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100). Breast Cancer Research and Treatment. 130: 855-61. PMID 21874312 DOI: 10.1007/S10549-011-1725-6 |
0.414 |
|
| 2011 |
Kahl BS, Hong F, Williams ME, Gascoyne RD, Wagner LI, Krauss JC, Horning SJ. Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma Blood. 118: LBA-6-LBA-6. DOI: 10.1182/Blood.V118.21.Lba-6.Lba-6 |
0.329 |
|
| 2011 |
Weiss M, Jacobus S, Wagner LI, Cella D, Katz MS, Rajkumar V, Fonseca R. Development of the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM) Scale and Validation in the Eastern Cooperative Oncology Group Trial E1A05, Blood. 118: 4184-4184. DOI: 10.1182/Blood.V118.21.4184.4184 |
0.358 |
|
| 2011 |
Wagner L, Zhao F, Chapman J, Cella D, Shepherd L, Sledge G, Goss P. S6-2: Patient-Reported Predictors of Early Treatment Discontinuation: NCIC JMA.27/E1Z03 Quality of Life Study of Postmenopausal Women with Primary Breast Cancer Randomized to Exemestane or Anastrozole. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-S6-2 |
0.411 |
|
| 2011 |
Tevaarwerk A, Gray R, Schneider B, Smith M, Wagner L, Miller K, Sparano J. P1-08-01: Survival in Metastatic Breast Cancer (MBC): No Evidence for Improved Survival Following Distant Recurrence after Adjuvant Chemotherapy. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-08-01 |
0.341 |
|
| 2010 |
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, ... ... Wagner LI, et al. Cancer-related fatigue Jnccn Journal of the National Comprehensive Cancer Network. 8: 904-931. PMID 20870636 DOI: 10.6004/Jnccn.2010.0067 |
0.401 |
|
| 2010 |
Fisch M, Lee J, Chang VT, Wagner LI, Cella D, Minasian LM, McCaskill-Stevens WJ, Weiss M, Smith M, Cleeland CS. A prospective evaluation of symptom change over 4 weeks for outpatients with common solid tumors: Results from E2Z02 (the SOAPP study). Journal of Clinical Oncology. 28: 9120-9120. DOI: 10.1200/Jco.2010.28.15_Suppl.9120 |
0.318 |
|
| 2010 |
Tevaarwerk A, Lee J, Sesto MC, Buhr KA, Cleeland CS, Manola J, Wagner LI, Chang VT, Fisch M. Predictors of employment (empl) outcomes in outpatients (pts) with common solid tumors: A secondary analysis from E2Z02 (ECOG's SOAPP study). Journal of Clinical Oncology. 28: 9118-9118. DOI: 10.1200/Jco.2010.28.15_Suppl.9118 |
0.316 |
|
| 2010 |
Hamann HA, Lee J, Schiller JH, Horn L, Cleeland CS, Manola J, Wagner LI, Chang VT, Fisch M. Clinician perceptions of care difficulty and quality of life for lung cancer patients: Results from the ECOG SOAPP study (E2Z02). Journal of Clinical Oncology. 28: 9102-9102. DOI: 10.1200/Jco.2010.28.15_Suppl.9102 |
0.336 |
|
| 2010 |
Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D. Longitudinal prospective assessment of sleep disturbance in breast cancer. Journal of Clinical Oncology. 28: 9101-9101. DOI: 10.1200/Jco.2010.28.15_Suppl.9101 |
0.306 |
|
| 2010 |
Jacobs D, Grimm SA, Rademaker A, Rice L, Chandler J, Muro K, Marymont MH, Helenowski IB, Wagner LI, Raizer JJ. Quality-of-life concordance between patients with malignant gliomas (MG) and their caregivers. Journal of Clinical Oncology. 28: 2041-2041. DOI: 10.1200/Jco.2010.28.15_Suppl.2041 |
0.337 |
|
| 2010 |
Tevaarwerk A, Lee J, Sesto M, Cleeland C, Wagner L, Chang V, Fisch M. Abstract P2-14-07: Predictors of Employment Outcomes in Breast Cancer (BrCa) Patients: An Analysis from E2Z02 (ECOG's SOAPP Study) Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-14-07 |
0.401 |
|
| 2009 |
Cardenes HR, Powell M, Loehrer PJ, Wagner LI, Cella DF, Brell J, Ramanathan RK, Crane CH, Alberts SR, Benson AB. E4201: Randomized phase II study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with locally advanced, unresectable, pancreatic cancer (LAPC): Quality-of-life (QOL) analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4627. PMID 27964205 DOI: 10.1200/Jco.2009.27.15_Suppl.4627 |
0.346 |
|
| 2009 |
Fisch M, Lee JW, Manola J, Wagner L, Chang V, Gilman P, Lear K, Baez L, Cleeland C. Survey of disease and treatment-related symptoms in outpatients with invasive cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9619. PMID 27963878 DOI: 10.1200/Jco.2009.27.15_Suppl.9619 |
0.383 |
|
| 2009 |
Lai JS, Butt Z, Wagner L, Sweet JJ, Beaumont JL, Vardy J, Jacobsen PB, Shapiro PJ, Jacobs SR, Cella D. Evaluating the dimensionality of perceived cognitive function. Journal of Pain and Symptom Management. 37: 982-95. PMID 19500722 DOI: 10.1016/J.Jpainsymman.2008.07.012 |
0.341 |
|
| 2008 |
Loehrer PJ, Powell ME, Cardenes HR, Wagner L, Brell JM, Ramanathan RK, Crane CH, Alberts SR, Benson AB. A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4506. PMID 27949235 DOI: 10.1200/Jco.2008.26.15_Suppl.4506 |
0.353 |
|
| 2008 |
Vardy JL, Xu W, Booth CM, Park A, Dodd A, Rourke S, Dhillon H, Clarke SJ, Wagner L, Tannock IF. Relation between perceived cognitive function and neuropsychological performance in survivors of breast and colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 9520. PMID 27948228 DOI: 10.1200/Jco.2008.26.15_Suppl.9520 |
0.335 |
|
| 2008 |
Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. Journal of Pain and Symptom Management. 35: 20-30. PMID 17959345 DOI: 10.1016/J.Jpainsymman.2007.02.040 |
0.36 |
|
| 2008 |
Wagner LI, Beaumont JL, Ding B, Malin J, Peterman A, Calhoun E, Cella D. Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: Validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N) Supportive Care in Cancer. 16: 47-56. PMID 17619911 DOI: 10.1007/S00520-007-0270-7 |
0.33 |
|
| 2008 |
Butt Z, Wagner LI, Beaumont JL, Paice JA, Straus JL, Peterman AH, Carro G, Von Roenn JH, Shevrin D, Cella D. Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy Supportive Care in Cancer. 16: 151-159. PMID 17609992 DOI: 10.1007/S00520-007-0291-2 |
0.351 |
|
| 2008 |
Witherspoon JN, Wagner L, Rademaker A, West DP, Rosenbaum SE, Lacouture ME. Correlation of patient characteristics and NCI-Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 grading with dermatology-related quality of life (QoL) in patients with EGFR inhibitor-induced rash Journal of Clinical Oncology. 26: 9559-9559. DOI: 10.1200/Jco.2008.26.15_Suppl.9559 |
0.364 |
|
| 2007 |
Mock V, Abernethy AP, Atkinson A, Barsevick AM, Berger AM, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Hinds P, Jacobsen PB, Kaldor P, O'Connor T, Otis-Green SA, ... ... Wagner LI, et al. Cancer-related fatigue clinical practice guidelines in oncology Jnccn Journal of the National Comprehensive Cancer Network. 5: 1054-1078. PMID 18053429 DOI: 10.6004/Jnccn.2007.0088 |
0.335 |
|
| 2007 |
Wagner LI, Wenzel L, Shaw E, Cella D. Patient-reported outcomes in phase II cancer clinical trials: Lessons learned and future directions Journal of Clinical Oncology. 25: 5058-5062. PMID 17991921 DOI: 10.1200/Jco.2007.11.7275 |
0.353 |
|
| 2007 |
Cella D, Wagner L, Cashy J, Hensing TA, Yount S, Lilenbaum RC. Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy Journal of the National Cancer Institute. Monographs. 53-60. PMID 17951232 DOI: 10.1093/Jncimonographs/Lgm009 |
0.416 |
|
| 2007 |
Jacobs SR, Jacobsen PB, Booth-Jones M, Wagner LI, Anasetti C. Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with Hematopoetic Stem Cell Transplant Patients Journal of Pain and Symptom Management. 33: 13-23. PMID 17196903 DOI: 10.1016/J.Jpainsymman.2006.06.011 |
0.335 |
|
| 2007 |
Wagner L, Lai SE, Aneja M, Lorusso P, Perez-Soler R, O’Brien B, Patel J, Lacouture ME. Development of a functional assessment of side-effects to therapy (FAST) questionnaire to assess dermatology-related quality of life in patients treated with EGFR inhibitors (EGFRI): The FAST-EGFRI Journal of Clinical Oncology. 25: 19532-19532. DOI: 10.1200/Jco.2007.25.18_Suppl.19532 |
0.31 |
|
| 2006 |
Vardy J, Wong K, Yi QL, Park A, Maruff P, Wagner L, Tannock IF. Assessing cognitive function in cancer patients Supportive Care in Cancer. 14: 1111-1118. PMID 16538498 DOI: 10.1007/S00520-006-0037-6 |
0.333 |
|
| 2006 |
Booth CM, Vardy J, Crawley A, Rourke S, Pond G, Wagner L, Tannock IF. Cognitive impairment associated with chemotherapy for breast cancer: An exploratory case-control study Journal of Clinical Oncology. 24: 8501-8501. DOI: 10.1200/Jco.2006.24.18_Suppl.8501 |
0.312 |
|
| 2006 |
Wagner LI, Sweet JJ, Butt Z, Beaumont J, Havlin KA, Sabatino T, Cella D. Trajectory of cognitive impairment during breast cancer treatment: A prospective analysis Journal of Clinical Oncology. 24: 8500-8500. DOI: 10.1200/Jco.2006.24.18_Suppl.8500 |
0.336 |
|
| 2006 |
Vardy J, Rourke S, Galica J, Pond GR, Park A, Zhang H, Clarke SJ, Dhillon H, Wagner L, Tannock IF. Cytokine levels in patients (pts) with localized colorectal cancer (CRC) after surgery and their relationship to fatigue and cognitive function Journal of Clinical Oncology. 24: 3623-3623. DOI: 10.1200/Jco.2006.24.18_Suppl.3623 |
0.302 |
|
| 2005 |
Wagner LI, Sweet JJ, Desai J, Beaumont J, Havlin KA, Butt ZA, Cella D. Prechemotherapy hemoglobin (Hgb) and cognitive impairment among breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8124. PMID 27947087 DOI: 10.1200/Jco.2005.23.16_Suppl.8124 |
0.335 |
|
| 2005 |
Joly F, Alibhai S, Galica J, Soban F, Park A, Yi QL, Wagner L, Tannock I. Impact of androgen deprivation therapy (ADT) on quality of life (QL), cognitive and physical function of patients with non-metastatic prostate cancer (PC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4627. PMID 27947005 DOI: 10.1200/Jco.2005.23.16_Suppl.4627 |
0.336 |
|
| 2005 |
Paterson AG, Trask PC, Wagner LI, Esper P, Redman B. Validation of the FACT-BRM with interferon-α treated melanoma patients Quality of Life Research. 14: 133-139. PMID 15789947 DOI: 10.1007/S11136-004-1694-X |
0.369 |
|
| 2004 |
Wagner LI, Sweet JJ, Cella D, Havlin KA, Forrestal S, Parrish T, Gitelman DR. Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 8023. PMID 28015829 DOI: 10.1200/Jco.2004.22.14_Suppl.8023 |
0.312 |
|
| 2004 |
Wagner LI, Cella D. Fatigue and cancer: Causes, prevalence and treatment approaches British Journal of Cancer. 91: 822-828. PMID 15238987 DOI: 10.1038/Sj.Bjc.6602012 |
0.395 |
|
| 1998 |
Jason LA, Wagner L, Rosenthal S, Goodlatte J, Lipkin D, Papernik M, Plioplys S, Plioplys AV. Estimating the prevalence of chronic fatigue syndrome among nurses. The American Journal of Medicine. 105: 91S-93S. PMID 9790488 DOI: 10.1016/S0002-9343(98)00159-4 |
0.373 |
|
| 1998 |
Jason LA, Wagner LI. Chronic Fatigue Syndrome Among Nurses American Journal of Nursing. 98: 16B. DOI: 10.1097/00000446-199805000-00010 |
0.42 |
|
| 1998 |
Jason LA, Richman JA, Friedberg F, Wagner L, Taylor R, Jordan KM. More On The Biopsychosocial Model Of Chronic Fatigue Syndrome American Psychologist. 53: 1081-1082. DOI: 10.1037//0003-066X.53.9.1081 |
0.565 |
|
| 1997 |
Wagner LI, Jason LA. Outcomes of occupational stressors on nurses: chronic fatigue syndrome--related symptoms. Nursingconnections. 10: 41-9. PMID 9397874 |
0.399 |
|
| 1997 |
Jason LA, Richman JA, Friedberg F, Wagner L, Taylor R, Jordan KM. Politics, science, and the emergence of a new disease. The case of chronic fatigue syndrome. The American Psychologist. 52: 973-83. PMID 9301342 DOI: 10.1037/0003-066X.52.9.973 |
0.545 |
|
| 1995 |
Jason LA, Taylor R, Wagner L, Holden J, Ferrari JR, Plioplys AV, Plioplys S, Lipkin D, Papernik M. Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study. American Journal of Community Psychology. 23: 557-68. PMID 8546110 DOI: 10.1007/Bf02506968 |
0.558 |
|
| 1995 |
Jason LA, Wagner L, Taylor R, Ropacki MT, Shlaes J, Ferrari JR, Slavich SP, Stenzel C. Chronic fatigue syndrome: A new challenge for health care professionals Journal of Community Psychology. 23: 143-164. DOI: 10.1002/1520-6629(199504)23:2<143::Aid-Jcop2290230205>3.0.Co;2-7 |
0.541 |
|
| 1994 |
Jason LA, Taylor SL, Johnson S, Goldston S, Salina D, Bishop P, Wagner L. Estimating Chronic Fatigue Syndrome-Related Symptoms Among Nurses: A Preliminary Report Clinical Infectious Diseases. 18: 54-54. DOI: 10.1093/Clinids/18.Supplement_1.S54-A |
0.635 |
|
| 1993 |
Jason LA, Taylor SL, Johnson S, Goldston SE, Salina D, Bishop P, Wagner L. Prevalence of chronic fatigue syndrome-related symptoms among nurses. Evaluation & the Health Professions. 16: 385-99. PMID 10130552 DOI: 10.1177/016327879301600403 |
0.62 |
|
| Show low-probability matches. |